CClinicalTrials.gg
CompletedNCT04009902Updated May 22, 2020

Evaluation of Depression and Sleep Disorders in Endometriosis Patients

An observational study in Endometriosis, Sleep and Depression, sponsored by Kanuni Sultan Suleyman Training and Research Hospital. Completed at 2 sites in Turkey. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2020-05-22.

Sponsored by Kanuni Sultan Suleyman Training and Research Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

The aim of this study was to compare the depression and sleep disturbances of operated endometriosis patients before and after the operation. The main objective here is to provide data on how patients' psychological states and sleep patterns are affected by the symptoms of endometriosis and how these effects can be corrected. In this way, it is aimed to determine whether the patients have psychological support needs and to give the planned treatment due to endometriosis in the early period. As a secondary goal, it is planned to keep the patients in follow-up with their improved sleep and psychological conditions, and to improve their adherence to treatment and quality of life.

02

Conditions studied

03

In context

Sleep Wake Disorders

788 studies on the registry are indexed under Sleep Wake Disorders; 186 are open to participants now.

This study's enrollment of 50 is below the median of 114 across 215 observational studies indexed under Sleep Wake Disorders.

Browse Sleep Wake Disorders studies →

Lead sponsor

Kanuni Sultan Suleyman Training and Research Hospital is the lead sponsor of 216 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study group included patients with indications for operation and who agreed to test for depression and sleep disorders.

Inclusion criteria

  • 18-49 years of age with no known psychiatric disorder and
  • Endometriosis patients with indications for operation

Exclusion criteria

Exclusion Criteria:

  • Patients receiving only medical treatment without any indication for operation,
  • those with a known psychiatric disease,
  • patients with sleep disorders due to another reason,
  • Patients over the age of 49, patients under the age of 18,
  • Patients with malignancy,
  • pregnant women
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (actual)
Patient registry
No

Interventions

  • BehavioralBeck Depression Scale and Pittsburgh Sleep Quality Index

    postoperative depression and sleep disorders in patients with endometriosis will be evaluated

06

What researchers measure

Primary outcomes

  1. Beck Depression Scale

    postoperative depression in endometriosis patients will be evaluated. Consists of 21 questions scored between 0-3. HIGH SCORE SHOWS TO HIGH DEPRESSION. (0-63 POINTS)

    Time frame: 1 week

  2. Pittsburgh Sleep Quality Index

    postoperative sleep disorders of endometriosis patients will be evaluated. Consists of 9 questions scored between 0-3. HIGH SCORE SHOWS BAD SLEEP QUALITY. (0-27 POINTS)

    Time frame: 1 week

07

Study locations

2 sites
  • Kanuni Sultan Süleyman Training and Research Hospital
    Istanbul, 33404, Turkey
  • Pınar Kadiroğulları
    Istanbul, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 22, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04009902
Lead sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Responsible party
Pınar Kadirogulları (Principal investigator, M.D, Department of Obstetrics and Gynecology, Kanuni Sultan Suleyman Training and Research Hospital) — Principal investigator
First posted
Jul 5, 2019
Start date
Jul 3, 2019
Primary completion
May 3, 2020
Completion
May 3, 2020
Last update
May 22, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion